Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 28, 2020 - Issue 7
Submit an article Journal homepage
262
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Persistent Placoid Maculopathy: Prognosis Factors and Functional Outcomes

Pierre Gascon1 North Hospital of Marseille, Marseille, France;2 Timone Institute of Neurosciences, CNRS, Aix-Marseille Université, Marseille, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2012-8808
, MDORCID Icon,
Frederic Matonti2 Timone Institute of Neurosciences, CNRS, Aix-Marseille Université, Marseille, France;3 Paradis Monticelli Centre, Marseille
, MD, PhD,
Marie Beylerian1 North Hospital of Marseille, Marseille, France
, MD,
Audrey Feldman4 LEO Centre, Saint-Priest, France
, MD,
Alban Comet1 North Hospital of Marseille, Marseille, France
, MD,
Benjamin Donnadieu1 North Hospital of Marseille, Marseille, France
, MD,
Olivier Loria5 Croix-Rousse university Hospital, Lyon, France
, MD,
Daniele Denis1 North Hospital of Marseille, Marseille, France
, MD, PhD,
Laurent Kodjikian5 Croix-Rousse university Hospital, Lyon, France;6 UMR-CNRS 5510 Matéis, Villeurbanne, France
, MD, PhD &
Thibaud Mathis5 Croix-Rousse university Hospital, Lyon, France;6 UMR-CNRS 5510 Matéis, Villeurbanne, France
, MD show all
Pages 1136-1148 | Received 28 Apr 2019, Accepted 15 Jul 2019, Published online: 16 Aug 2019

References

  • Golchet PR, Jampol LM, Wilson D, Yannuzzi LA, Ober M, Stroh E. Persistent placoid maculopathy: a new clinical entity. Trans Am Ophthalmol Soc. 2006;104:108–120.
  • Golchet PR, Jampol LM, Wilson D, Yannuzzi LA, Ober M, Stroh E. Persistent placoid maculopathy: a new clinical entity. Ophthalmology. 2007;114(8):1530–1540. doi:10.1016/j.ophtha.2006.10.050.
  • Gendy MG, Fawzi AA, Wendel RT, Pieramici DJ, Miller JA, Jampol LM. Multimodal imaging in persistent placoid maculopathy. JAMA Ophthalmol. 2014;132(1):38–49. doi:10.1001/jamaophthalmol.2013.6310.
  • Puche N, Hera R, Terrada C, Souied EH. PERSISTENT PLACOID MACULOPATHY IMAGED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retin Cases Brief Rep. April 2016;10:297–301. doi:10.1097/ICB.0000000000000303.
  • Klufas MA, Phasukkijwatana N, Iafe NA, et al. Optical coherence tomography angiography reveals choriocapillaris flow reduction in placoid chorioretinitis. Ophthalmol Retina. 2017;1(1):77–91.doi:10.1016/j.oret.2016.08.008.
  • Nika M, Kalyani PS, Jayasundera KT, Comer GM. pathogenesis of persistent placoid maculopathy: a multimodal imaging analysis. Retina (Philadelphia, Pa). 2015;35(8):1531–1539. doi:10.1097/IAE.0000000000000496.
  • Parodi MB, Iacono P, Bandello F. Juxtafoveal choroidal neovascularization secondary to persistent placoid maculopathy treated with intravitreal bevacizumab. Ocul Immunol Inflamm. 2010;18(5):399–401. doi:10.3109/09273948.2010.483316.
  • Waisbren EC, Ho J, Smithen LM, Yannuzzi LA, Duker JS. Using ranibizumab to successfully treat choroidal neovascularization in a patient with persistent placoid maculopathy. Retin Cases Brief Rep. 2010;4(3):211–215. doi:10.1097/ICB.0b013e3181c59791.
  • Eadie JA, Gottlieb JL. Successful treatment of choroidal neovascularization secondary to persistent placoid maculopathy with intravitreal bevacizumab. Retin Cases Brief Rep. 2014;8(1):37–40. doi:10.1097/ICB.0b013e3182a48c07.
  • Kovach JL. Persistent placoid maculopathy imaged with spectral domain OCT and autofluorescence. Ophthalmic Surg Lasers Imaging. 2010;41(Suppl):S101–103. doi:10.3928/15428877-20101031-11.
  • Lenassi E, Kojovic M, Jaki Mekjavić P, Sega S, Vidovič Valentinčič N. Persistent placoid maculopathy complicated by cerebral vasculitis. J Neuroophthalmol. 2017;37(3):273–275. doi:10.1097/WNO.0000000000000399.
  • Sassalos TM, Saraf SS, Ober MD. Chorioretinal perfusion in persistent placoid maculopathy. Ophthalmic Surg Lasers Imaging Retina. 2017;48(12):1026–1031. doi:10.3928/23258160-20171130-12.
  • Kolomeyer AM, Brucker AJ. persistent placoid maculopathy in a patient with high Myopia. Retin Cases Brief Rep. August 2018. doi:10.1097/ICB.0000000000000818.
  • Kolomeyer AM, Brucker AJ. Persistent placoid maculopathy: a systematic review. Retina (Philadelphia, Pa). 2018;38(10):1881–1895. doi:10.1097/IAE.0000000000002284.
  • Kniestedt C, Stamper RL. Visual acuity and its measurement. Ophthalmol Clin North Am. 2003;16:155–170.
  • Khairallah M, Ben Yahia S. Persistent placoid maculopathy. Ophthalmology. 2008;115(1):220–221. doi:10.1016/j.ophtha.2007.09.014.
  • Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419–1431. doi:10.1056/NEJMoa054481.
  • Dʼsouza P, Ranjan R, Babu U, Kanakath AV, Saravanan VR. INFLAMMATORY CHOROIDAL NEOVASCULAR MEMBRANE: long-term visual and anatomical outcomes after intravitreal anti-vascular endothelial growth factor therapy. Retina (Philadelphia, Pa). 2018;38(7):1307–1315. doi:10.1097/IAE.0000000000001710.
  • Roberts PK, Nesper PL, Onishi AC, Skondra D, Jampol LM, Fawzi AA. Characterizing photoreceptor changes in acute posterior multifocal placoid pigment epitheliopathy using adaptive optics. Retina (Philadelphia, Pa). 2018;38(1):39–48. doi:10.1097/IAE.0000000000001520.
  • Jacob J, Paques M, Krivosic V, et al. Meaning of visualizing retinal cone mosaic on adaptive optics images. Am J Ophthalmol. 2015;159(1):118–123.e1.doi:10.1016/j.ajo.2014.09.043.
  • Lim W-K, Buggage RR, Nussenblatt RB. Serpiginous choroiditis. Surv Ophthalmol. 2005;50(3):231–244. doi:10.1016/j.survophthal.2005.02.010.
  • Munteanu G, Munteanu M, Zolog I. [Serpiginous choroiditis - clinical study]. Oftalmologia. 2001;52:72–80.
  • Jones NP. Acute posterior multifocal placoid pigment epitheliopathy. Br J Ophthalmol. 1995;79(4):384–389. doi:10.1136/bjo.79.4.384.
  • Eandi CM, Neri P, Adelman RA, Yannuzzi LA, Cunningham ET. International Syphilis study group. Acute syphilitic posterior placoid chorioretinitis: report of a case series and comprehensive review of the literature. Retina (Philadelphia, Pa). 2012;32(9):1915–1941. doi:10.1097/IAE.0b013e31825f3851.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.